These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18855910)

  • 1. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
    Martins FT; Neves PP; Ellena J; Camí GE; Brusau EV; Narda GE
    J Pharm Sci; 2009 Jul; 98(7):2336-44. PubMed ID: 18855910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
    de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
    J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
    Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
    J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mebendazole mesylate monohydrate: a new route to improve the solubility of mebendazole polymorphs.
    de Paula K; Camí GE; Brusau EV; Narda GE; Ellena J
    J Pharm Sci; 2013 Oct; 102(10):3528-38. PubMed ID: 23897162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of solid-state forms of mebendazole.
    Kumar S; Chawla G; Sobhia ME; Bansal AK
    Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure determination of mebendazole form A using high-resolution synchrotron x-ray powder diffraction data.
    Ferreira FF; Antonio SG; Rosa PC; Paiva-Santos Cde O
    J Pharm Sci; 2010 Apr; 99(4):1734-44. PubMed ID: 19655377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
    Brits M; Liebenberg W; de Villiers MM
    J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
    Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
    Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
    Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
    Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
    Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the electrokinetic properties on the stability of mebendazole suspensions for veterinary applications.
    Cózar-Bernal MJ; Gallardo V; Sáez-Fernández E; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Arias JL
    Int J Pharm; 2010 Jun; 393(1-2):161-6. PubMed ID: 20435113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthelmintic efficacy of mebendazole depends on the molecular polymorph.
    Evans AC; Fincham JE; Dhansay MA; Liebenberg W
    S Afr Med J; 1999 Nov; 89(11):1118. PubMed ID: 10599275
    [No Abstract]   [Full Text] [Related]  

  • 13. Spherical crystallization of mebendazole to improve processability.
    Kumar S; Chawla G; Bansal AK
    Pharm Dev Technol; 2008; 13(6):559-68. PubMed ID: 18720249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexes of β-cyclodextrin and polymorphs of mebendazole: Physicochemical characterization.
    Saidman E; Chattah AK; Aragón L; Sancho M; Camí G; Garnero C; Longhi M
    Eur J Pharm Sci; 2019 Jan; 127():330-338. PubMed ID: 30445224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two polymorphs of N-(2-methoxyphenyl)-4-oxo-4H-chromone-3-carboxamide.
    Gomes LR; Low JN; Borges F; Cagide F
    Acta Crystallogr C; 2013 Aug; 69(Pt 8):927-33. PubMed ID: 23907891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility, 1H-NMR, and molecular mechanics of mebendazole with different cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia-Mora J; Escobar Llanos CM
    Drug Dev Ind Pharm; 1999 Jan; 25(1):111-5. PubMed ID: 10028428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms.
    Rodriguez-Caabeiro F; Criado-Fornelio A; Jimenez-Gonzalez A; Guzman L; Igual A; Perez A; Pujol M
    Chemotherapy; 1987; 33(4):266-71. PubMed ID: 3608627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supramolecular synthesis based on piperidone derivatives and pharmaceutically acceptable co-formers.
    Sandhu B; Draguta S; Kinnibrugh TL; Khrustalev VN; Timofeeva TV
    Acta Crystallogr C; 2013 Apr; 69(Pt 4):421-7. PubMed ID: 23579720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal form III of beta-cyclodextrin-ethanol inclusion complex: layer-type structure with dimeric motif.
    Aree T; Chaichit N
    Carbohydr Res; 2008 Sep; 343(13):2285-91. PubMed ID: 18490008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.